INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
47 hedge funds and large institutions have $149M invested in Inozyme Pharma in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
6% less funds holding
Funds holding: 50 → 47 (-3)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Holders
47
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$15.5M | |
| 2 | +$12.9M | |
| 3 | +$7.76M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$6.9M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.56M |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$2.14M | |
| 3 | -$668K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$319K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$172K |